Overactive Bladder - Results from #2140

STEP Study results demonstrate sustained therapeutic effects of percutaneous tibial nerve stimulation at 24 months June 6, 2012

Medical treatment of overactive bladder: An overview - Abstract June 6, 2012

Unusual findings on cystoscopy in a patient with detrusor overactivity - Abstract June 5, 2012

Associations between subjective overactive bladder symptoms and objective parameters on bladder diary and filling cystometry - Abstract June 4, 2012

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: A retrospective cohort study - Abstract June 1, 2012

Female overactive bladder syndrome and autonomic nervous system - Abstract June 1, 2012

Socioeconomic costs of overactive bladder and stress urinary incontinence in Korea - Abstract May 31, 2012

AUA 2012 - Neurostimulation treatment for overactive bladder: An evaluation of cost effectiveness data - Slide Presentation May 29, 2012

AUA 2012 - Neurostimulation treatment for overactive bladder: An evaluation of cost effectiveness data - Abstract May 29, 2012

AUA 2012 - Neurostimulation treatment for overactive bladder: An evaluation of cost effectiveness data - Poster May 29, 2012

Alterations of heart rate variability in women with overactive bladder syndrome - Abstract May 29, 2012

AUA 2012 - 30 month study results using percutaneous tibial nerve stimulation: Long term efficacy outcomes - Slide Presentation May 29, 2012

AUA 2012 - 30 month study results using percutaneous tibial nerve stimulation: Long term efficacy outcomes - Abstract May 29, 2012

AUA 2012 - 30 month study results using percutaneous tibial nerve stimulation: Long term efficacy outcomes - Poster May 29, 2012

AUA 2012 - Evaluating patients' symptoms of overactive bladder by questionnaire: The role of urgency on urinary frequency - Session Highlights May 29, 2012

AUA 2012 - The urodynamic safety of mirabegron based on a phase II bladder outlet obstruction (BOO) clinical trial - Special Report May 29, 2012

Reliability and validity of the overactive bladder symptom score in Spanish (OABSS-S) - Abstract May 28, 2012

AUA 2012 - AUA guidelines emphasizes behavioral therapies, medications to treat overactive bladder - Press Release May 23, 2012

Efficacy of solifenacin for overactive bladder symptoms, symptom bother, and health-related quality of life in patients by duration of self-reported symptoms: A secondary analysis of the VIBRANT study - Abstract May 21, 2012

Brain activity underlying impaired continence control in older women with overactive bladder - Abstract May 18, 2012

Page 108 of 120